FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Abbadessa G, Chianese U, Russo C, Miele G, Maida E, Esposito G, Romano G, Bile F, Signoriello E, Lus G, Lavorgna L, Nicholas RS, Altucci L, Procaccini C, Matarese G, Benedetti R, Bonavita S.